Literature DB >> 31241180

A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.

Atsushi Hata1,2, Takahiro Nakajima1, Keisuke Matsusaka2, Masaki Fukuyo2,3, Junichi Morimoto1, Takayoshi Yamamoto1, Yuichi Sakairi1, Bahityar Rahmutulla2, Satoshi Ota4, Hironobu Wada1, Hidemi Suzuki1, Hisahiro Matsubara5, Ichiro Yoshino1, Atsushi Kaneda2.   

Abstract

Patients with idiopathic pulmonary fibrosis (IPF) have higher risk of developing lung cancer, for example, squamous cell carcinoma (SCC), and show poor prognosis, while the molecular basis has not been fully investigated. Here we conducted DNA methylome analysis of lung SCC using 20 SCC samples with/without IPF, and noncancerous lung tissue samples from smokers/nonsmokers, using Infinium HumanMethylation 450K array. SCC was clustered into low- and high-methylation epigenotypes by hierarchical clustering analysis. Genes hypermethylated in SCC significantly included genes targeted by polycomb repressive complex in embryonic stem cells, and genes associated with Gene Ontology terms, for example, "transcription" and "cell adhesion," while genes hypermethylated specifically in high-methylation subgroup significantly included genes associated with "negative regulation of growth." Low-methylation subgroup significantly correlated with IPF (78%, vs. 17% in high-methylation subgroup, p = 0.04), and the correlation was validated by additional Infinium analysis of SCC samples (n = 44 in total), and data from The Cancer Genome Atlas (n = 390). The correlation between low-methylation subgroup and IPF was further validated by quantitative methylation analysis of marker genes commonly hypermethylated in SCC (HOXA2, HOXA9 and PCDHGB6), and markers specifically hypermethylated in high-methylation subgroup (DLEC1, CFTR, MT1M, CRIP3 and ALDH7A1) in 77 SCC cases using pyrosequencing (p = 0.003). Furthermore, low-methylation epigenotype significantly correlated with poorer prognosis among all SCC patients, or among patients without IPF. Multivariate analysis showed that low-methylation epigenotype is an independent predictor of poor prognosis. These may suggest that lung SCC could be stratified into molecular subtypes with distinct prognosis, and low-methylation lung SCC that significantly correlates with IPF shows unfavorable outcome.
© 2019 UICC.

Entities:  

Keywords:  DNA methylation; idiopathic pulmonary fibrosis; lung cancer; squamous cell carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31241180     DOI: 10.1002/ijc.32532

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  DNA methylation in pulmonary fibrosis and lung cancer.

Authors:  Juan Duan; Baiyun Zhong; Zhihua Fan; Hao Zhang; Mengmeng Xu; Xiangyu Zhang; Yan Y Sanders
Journal:  Expert Rev Respir Med       Date:  2022-06-08       Impact factor: 4.300

2.  The impact of ALDH7A1 variants in oral cancer development and prognosis.

Authors:  Hsueh-Ju Lu; Chun-Yi Chuang; Mu-Kuan Chen; Chun-Wen Su; Wei-En Yang; Chia-Ming Yeh; Kuan-Ming Lai; Chih-Hsin Tang; Chiao-Wen Lin; Shun-Fa Yang
Journal:  Aging (Albany NY)       Date:  2022-05-25       Impact factor: 5.955

Review 3.  CFTR and Gastrointestinal Cancers: An Update.

Authors:  Rahul Bhattacharya; Zachary Blankenheim; Patricia M Scott; Robert T Cormier
Journal:  J Pers Med       Date:  2022-05-25

4.  Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.

Authors:  Yosuke Yamamoto; Keisuke Matsusaka; Masaki Fukuyo; Bahityar Rahmutulla; Hiroyuki Matsue; Atsushi Kaneda
Journal:  Cancer Med       Date:  2020-05-14       Impact factor: 4.452

Review 5.  Methylation in HOX Clusters and Its Applications in Cancer Therapy.

Authors:  Ana Paço; Simone Aparecida de Bessa Garcia; Renata Freitas
Journal:  Cells       Date:  2020-07-03       Impact factor: 6.600

6.  E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma.

Authors:  Jing Xu; Fengtian Li; Ya Gao; Rongtian Guo; Liangping Ding; Mengyuan Fu; Yong Yi; Hu Chen; Zhi-Xiong Jim Xiao; Mengmeng Niu
Journal:  Cell Death Dis       Date:  2021-04-08       Impact factor: 9.685

7.  High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.

Authors:  Wenxin Kou; Bo Li; Yeifei Shi; Yifan Zhao; Qing Yu; Jianhui Zhuang; Yawei Xu; Wenhui Peng
Journal:  BMC Cancer       Date:  2022-01-25       Impact factor: 4.430

8.  Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells.

Authors:  Esther Schamschula; Angelika Lahnsteiner; Yassen Assenov; Wolfgang Hagmann; Nadja Zaborsky; Markus Wiederstein; Anna Strobl; Frauke Stanke; Thomas Muley; Christoph Plass; Burkhard Tümmler; Angela Risch
Journal:  Epigenetics       Date:  2021-08-20       Impact factor: 4.861

9.  A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.

Authors:  Ming Zhang; Libing Sun; Yi Ru; Shasha Zhang; Junjun Miao; Pengda Guo; Jinghuan Lv; Feng Guo; Biao Liu
Journal:  Int J Mol Med       Date:  2020-04-27       Impact factor: 4.101

10.  Metallothionein 1M (MT1M) inhibits lung adenocarcinoma cell viability, migration, and expression of cell mobility-related proteins through MDM2/p53/MT1M signaling.

Authors:  Wei Xu; Guo-Jun Jiang; Guo-Zhen Shi; Ming-Zhi Chen; Tie-Liang Ma; Yong-Fei Tan
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.